Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy symbols : Iova save search
Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung Cancer
Published: 2023-07-25 (Crawled : 20:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 0.28%
H: 2.53%
C: -0.84%
lung conference world cancer tumor therapy
Iovance Biotherapeutics Announces Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer
Published: 2023-07-10 (Crawled : 11:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 0.69%
H: 20.92%
C: 20.58%
lung cancer cell therapy
Iovance Biotherapeutics Announces First Patient Dosed with PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy
Published: 2022-10-10 (Crawled : 12:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: -0.82%
H: 0.72%
C: -10.73%
CLLS | $2.48 0.81% 0.4% 15K
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: -4.47%
therapy
Iovance Biotherapeutics to Present Clinical Data for Lifileucel Tumor Infiltrating Lymphocyte (TIL) Therapy in Advanced Melanoma at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
Published: 2022-10-05 (Crawled : 12:20) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: -2.3%
H: 2.35%
C: 0.82%
melanoma immunotherapy meeting therapy
Iovance Biotherapeutics to Present at Chardan Genetic Medicines and Cell Therapy Manufacturing Summit
Published: 2022-04-25 (Crawled : 21:00) - biospace.com/
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
genetic therapy
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Cancers at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-11-13 (Crawled : 00:20) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
| Email alert
Add to watchlist
immunotherapy therapy cancer iot
Iovance Biotherapeutics Announces Clinical Data for LN-145 in Non-Small Cell Lung Cancer at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-11-12 (Crawled : 22:00) - biospace.com/
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: -2.55%
H: 0.0%
C: 0.0%
immunotherapy lung cancer therapy cancer iot
Iovance Biotherapeutics Announces Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Cell Therapy in Multiple Solid Tumors at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-11-09 (Crawled : 14:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: -0.36%
H: 4.65%
C: -0.64%
immunotherapy solid tumors therapy cancer iot
Iovance Biotherapeutics to Host Conference Call and Webcast to Highlight Data at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-10-18 (Crawled : 00:00) - biospace.com/
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: -0.41%
H: 0.38%
C: -3.62%
immunotherapy therapy cancer iot conference
Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Cell Therapies Across Multiple Solid Tumors and Treatment Settings at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:00) - biospace.com/
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: -0.69%
H: 9.02%
C: 7.59%
treatment immunotherapy solid tumors therapy cancer iot
Iovance Biotherapeutics Celebrates Grand Opening of Iovance Cell Therapy Center (iCTC) in the Philadelphia Navy Yard
Published: 2021-09-28 (Crawled : 22:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 0.93%
H: 2.01%
C: -4.27%
therapy iot
Iovance Biotherapeutics Initiates Clinical Supply of Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy Manufactured at Iovance Cell Therapy Center (iCTC)
Published: 2021-09-23 (Crawled : 12:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 0.68%
H: 2.11%
C: 1.87%
therapy iot
Global Cell and Gene Therapy Manufacturing Market Report 2021-2025: Expected Capacity Crunch, Investments for CGT Capacity Expansion, Events Driving Expansion for CGT Facilities and Infrastructure
Published: 2021-06-21 (Crawled : 17:00) - prnewswire.com
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.73%
H: 1.51%
C: 1.21%
LEGN | $47.16 -3.42% -3.54% 820K
|
Health Technology
|
| O: 0.11%
H: 4.08%
C: 2.68%
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: -0.44%
H: 1.3%
C: 0.65%
CDMO M | $6.54 -2.53% -2.6% 710K
|
Health Technology
|
| O: -0.17%
H: 3.29%
C: 1.6%
expansion gene therapy therapy gene therapies
Journal of Clinical Oncology Publishes Clinical Data for Cohort 2 in Iovance C-144-01 Study of Lifileucel TIL Therapy in Metastatic Melanoma
Published: 2021-05-12 (Crawled : 21:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 1.0%
H: 3.91%
C: -5.05%
therapy xin
Iovance Biotherapeutics to Present Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at American Association for Cancer Research (AACR) 2021 Annual Meeting
Published: 2021-03-10 (Crawled : 23:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 3.89%
H: 2.63%
C: 1.54%
therapy cancer research iot
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.